Healthcare & Life Sciences

Lead Generation for Pharmaceuticals & Biotech

SalesHive is a B2B lead generation agency that books qualified meetings for pharmaceutical and biotech companies selling to scientific buyers across R and D, clinical, regulatory, manufacturing, and commercial teams. SDR teams run compliant outbound across targeted lists, personalized email, and cold calling, positioning offers for Clinical Operations, Regulatory Affairs, and Market Access leaders who weigh validation and risk as heavily as features. Outreach respects strict compliance boundaries and the long evaluation cycles where deal momentum stalls as priorities shift from discovery to clinical or launch to lifecycle management.

All industries

47+ industries · 100% US-based SDRs · No long-term contracts

0K+
Qualified meetings booked
$0.0B+
Pipeline generated
0
Clients scaled
0%
US-based SDRs
The Challenge

Why Pharmaceuticals & Biotech Sales Development is Hard

Between tight compliance requirements and complex access dynamics, where the three largest PBMs process nearly 80% of U.S. prescriptions, teams need precise targeting and disciplined messaging to earn meetings.

Compliance-first outreach expectations

Pharma and biotech buyers are trained to spot risk, especially around claims, inducements, and how data is handled. If your messaging feels promotional, unsubstantiated, or unclear on intended use, it can end the conversation before it starts.

Slow evaluation and onboarding

Even when there’s urgency, vendor onboarding often requires security reviews, quality oversight, and cross-functional approvals. Sales cycles stretch when prospects need validation plans, SOP alignment, and internal buy-in before a pilot can begin.

Many stakeholders, no clear owner

Purchasing decisions span R&D, clinical, QA, IT, procurement, and commercial teams, each with different success metrics. A single champion rarely controls the process, so progress depends on building consensus across the account.

Budget volatility and reprioritization

Biotech budgets can change quickly with financing cycles, trial results, partnership news, or internal portfolio decisions. A project that looked funded last month can be paused, re-scoped, or moved to a different team overnight.

Heavy documentation requirements

Life sciences buyers often expect proof, not promises, quality documentation, audit readiness, and clear contractual language. If you can’t quickly provide the right artifacts and answers, prospects may choose a “safer” incumbent.

Market access and pricing pressure

Commercial teams face ongoing pressure from payers, formulary controls, and pricing scrutiny, which raises the bar for ROI on any new initiative. Vendors must connect value directly to outcomes like launch readiness, speed-to-insight, or operational efficiency.

Our Approach

How We Generate Leads for Pharmaceuticals & Biotech

We combine compliant messaging, precise list building, and persistent multi-threaded outreach to book meetings with the right life sciences stakeholders at the right moment.

Compliant email outreach

We build messaging that respects industry guardrails while still creating urgency, grounded in use cases like clinical operations efficiency, quality readiness, manufacturing continuity, or commercial execution. Sequences are tailored by persona and lifecycle stage (discovery, clinical, tech transfer, launch, post-market).

Cold calling for access

When inboxes are crowded and gatekeeping is real, calling helps you break into target accounts and identify the true owners of initiatives. Our SDRs use structured call plays to multi-thread across functions and convert interest into scheduled meetings.

Lifecycle-based list building

We build and QA lists aligned to how pharma and biotech actually buy, by therapeutic area, modality, trial phase, manufacturing footprint, and commercial maturity. That means fewer wasted touches and more conversations with teams that have an active need right now.

Personalization at scale

SalesHive’s platform and AI-driven personalization help your outreach feel relevant without slowing down execution. We continuously optimize deliverability, messaging performance, and account coverage so you can forecast pipeline with confidence.

Who we reach

We Target Your Ideal Pharmaceuticals & Biotech Buyers

Our SDRs are trained to engage life sciences stakeholders with compliant, technical messaging tailored to therapeutic area, modality, and where the organization sits in the development-to-commercialization lifecycle.

Decision-Makers We Reach

  • VP / Head of Clinical Operations
  • Director of Regulatory Affairs
  • VP, Technical Operations (Manufacturing / MSAT)
  • Head of Market Access & Payer Strategy
  • Director of Commercial Operations / Sales Operations
Questions, answered

Pharmaceuticals & Biotech outbound, explained

The short version is on the surface. Open any question to go deeper.

Pharma and biotech buyers expect compliance-first, evidence-based messaging, and they quickly disengage from anything that sounds like an unsubstantiated claim or unclear “intended use.” Sales cycles are also slower because decisions span R&D, clinical, quality, IT, procurement, and commercial teams, often requiring security reviews, validation expectations, and documented processes before a pilot even starts. On top of that, priorities can shift fast with trial timelines, portfolio changes, or financing events, which can stall deals mid-stream.
The right targets depend on where an organization sits in the development-to-commercialization lifecycle and what outcome you impact (trial execution, quality readiness, manufacturing continuity, launch performance, or market access). We commonly build account maps that include clinical operations, regulatory/quality, technical operations (MSAT/manufacturing), and commercial operations, then multi-thread outreach to find the real initiative owner. This reduces “dead-end” conversations and increases the odds of booking a meeting that can actually move forward.
We help you lead with precise, non-promotional positioning focused on operational outcomes and validated use cases, while avoiding language that can trigger compliance concerns (e.g., exaggerated performance claims or ambiguous data handling). Our team tailors sequences by persona and lifecycle stage, and we use our AI-powered platform with eMod personalization to make messages feel relevant without sacrificing consistency. We also continuously monitor deliverability and reply signals so you can scale outreach while protecting your domain reputation.
Yes, calling is often the fastest way to confirm who owns an initiative, understand what “stage” the account is in (clinical, tech transfer, launch, post-market), and route around inbox congestion. We use structured call plays designed for life sciences stakeholders, focusing on permission-based conversations and clear next steps rather than pushy pitching. Cold calling also enables multi-threading across functions to build consensus and convert interest into scheduled meetings.
Expect detailed questions about security, data handling, quality processes, validation expectations, and contract language, often before a formal pilot is approved. We help by pre-qualifying accounts during outreach, capturing requirements early, and setting meetings with the right stakeholders so your team isn’t stuck repeating discovery with non-decision makers. If needed, we can also adjust targeting and messaging quickly on our month-to-month model as new objections and documentation requirements surface.
Proof, by the numbers

A decade of meetings that turned into pipeline

129K+
Qualified meetings booked
$2.5B+
Pipeline generated for clients
47+
Industries served

Ready to fill your pipeline in Pharmaceuticals & Biotech?

Book a 30-minute strategy call and we will map out exactly how SalesHive books meetings with the buyers in your vertical.

See pricing